483 Astellas Pharma Tech Mar 2018

483 Astellas Pharma Tech Mar 2018

Saied Asbagh FDA$119.00 - Available Now

FDA investigators audited the Astellas Pharma Tech - Toyama, Japan facility and issued inspectional observations (via FDA 483) on 02 Mar 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 02 Mar 2018
  • Location: Toyama, Japan
  • FEI: 3002807003
Add To Cart